Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Medlive Technology Co., Ltd. ( (HK:2192) ) just unveiled an announcement.
Medlive Technology Co., Ltd. announced an interim dividend of RMB 0.1166 per share for the six months ended 30 June 2025, with a payment date set for 25 September 2025. This announcement reflects the company’s financial health and commitment to providing returns to its shareholders, potentially strengthening its market position and investor confidence.
The most recent analyst rating on (HK:2192) stock is a Buy with a HK$16.50 price target. To see the full list of analyst forecasts on Medlive Technology Co., Ltd. stock, see the HK:2192 Stock Forecast page.
More about Medlive Technology Co., Ltd.
Medlive Technology Co., Ltd. operates in the technology sector, focusing on providing digital healthcare solutions and services. The company is known for its innovative approaches in the healthcare industry, aiming to enhance medical services and patient care through technology.
Average Trading Volume: 3,479,797
Technical Sentiment Signal: Buy
Current Market Cap: HK$10.59B
For a thorough assessment of 2192 stock, go to TipRanks’ Stock Analysis page.